Clinical Trial Update: Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar

View source ↗

Summary

The completed trial in Myanmar assessed molecular markers of artemisinin resistance in malaria and reported on Day-3 parasitaemia and resistance gene mutations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: Myat Htut Nyunt | Conditions: Day-3 Positive of Parasitaemia, Prevalence of Drug Resistance Gene Mutation | Status: COMPLETED